Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban for Inflammation in HIV
NCT02339415Phase 2Completed
- Sponsor
- Hennepin Healthcare Research Institute
- Start
- Jul 2015
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Edoxaban with Placebo (2 arms). Primary endpoint: Change in Interleukin 6 Plasma Levels at 4 months. Started Jul 2015; status: completed.
02
Drugs
edoxaban
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02339415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02339415.